Determining personalized treatment by gene expression profiling in metastatic breast carcinoma patients: a pilot study
2018
Purpose
The present study evaluates the massive study of gene expression in metastatic breast carcinoma (MBC) patients using microarray gene expression profiling (MAGE) complemented with conventional sequencing, immunohistochemistry (IHC) and fluorescent “in situ” hybridization (FISH), seeking to optimize the treatment in a subset of heavily pretreated patients and with limited life expectancy.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
21
References
2
Citations
NaN
KQI